1-17 of 17
Jumei Shi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ferroportin Downregulation Promotes Cell Proliferation By Modulating the Nrf2-Mir 17-5p Axis in Multiple Myeloma

Jumei Shi, MD, Yuanyuan Kong, PhD, Liangning Hu, Gege Chen, Dandan Yu, Yongsheng Xie, Yingcong Wang, Xiaosong Wu
Journal: Blood
Blood (2019) 134 (Supplement_1): 5596.
https://doi.org/10.1182/blood-2019-131679
Published: 2019
Journal Articles

FPN1, Targeted By Mir-17-5p, Regulates Cellular Iron Homeostasis Via activating Nrf2/Mir-17-5p/FPN1 Axis in Preclinical Model of Multiple Myeloma

Yuanyuan Kong, Shuaikang Chang, Liangning Hu, Gege Chen, Yi Tao, Yingcong Wang, Dandan Yu, Kang Lu, Yongsheng Xie, Wenxuan Bu, Jumei Shi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5616.
https://doi.org/10.1182/blood-2018-99-112230
Published: 2018
Journal Articles

Carfilzomib Enhances Natural Killer Cell-Mediated Lysis of Myeloma Linked with Decreasing Expression of HLA Class I

Jumei Shi, MD, PhD, Guang Yang, Yuanyuan Kong, Minjie Gao, Yi Tao, Yiwen Zhang, Xiaosong Wu
Journal: Blood
Blood (2015) 126 (23): 1854.
https://doi.org/10.1182/blood.V126.23.1854.1854
Published: 2015
Journal Articles

Exome Sequencing Identifies Somatic Mutations of DDX3X in Natural Killer/T-Cell Lymphoma

Lu Jiang, PhD, Zhao-Hui Gu, PhD, Zi-Xun Yan, PhD, Xia Zhao, MD, Yin-Yin Xie, PhD, Zi-Guan Zhang, B.S., Chun-Ming Pan, M.S., Yuan Hu, MD, Chang-Ping Cai, MD, Ying Dong, MD, Li Wang, MD, Yang Shen, MD, Guoyu Meng, PhD, Jian-Feng Zhou, MD, PhD, Jian-Da Hu, MD, PhD, Jin-Fen Wang, MD, Lin-Hua Yang, MD, Feng Zhang, MD, Jian-Min Wang, MD, Zhao Wang, MD, Zhi-Gang Peng, MD, Fang-Yuan Chen, MD, Zi-Min Sun, MD, Hao Ding, MD, Jin-Yan Huang, PhD, Yuan-Hua Liu, MD, Jumei Shi, MD, PhD, Jian Hou, MD, Jin-Song Yan, MD, PhD, Jing-Yi Shi, PhD, Lan Xu, PhD, Yang Li, MD, Jing Lu, B.S., Zhong Zheng, MD, Wen Xue, B.S., Wei-Li Zhao, MD, PhD, Zhu Chen, MD, PhD, Sai-Juan Chen, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 1663.
https://doi.org/10.1182/blood.V124.21.1663.1663
Published: 2014
Journal Articles

High Trip13 and Low P31 Comet Cause Drug Resistance and Poor Prognosis In Multiple Myeloma

Yi Tao, MD&PhD, Zhimin Gu, PhD, Ye Yang, PhD, Hongwei Xu, DDS, Xiaojing Hu, Guido J. Tricot, M.D., Ph.D., Fenghuang Zhan, MD&PhD, Jumei Shi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3820.
https://doi.org/10.1182/blood.V122.21.3820.3820
Published: 2013
Journal Articles

Valproic Acid Upregulates NKG2D Ligand Expression and Potentially Enhances Natural Killer Cell–mediated Cytolysis of Myeloma

Jumei Shi, MD, PhD, Yi Tao, Xiaosong Wu, Xiaojing Hu, Yang Shao, Jun Hou
Journal: Blood
Blood (2011) 118 (21): 5061.
https://doi.org/10.1182/blood.V118.21.5061.5061
Published: 2011
Journal Articles

TRAIL as the ATO-Target Gene Uniquely Activated In the Hyperdiploid Subtype of Myeloma with Prognostic Relevance, Resulting In Better Prognosis

Jumei Shi, MD, PhD, Jun Hou, Yi Tao, Xiuqin Meng, Ying Han, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1904.
https://doi.org/10.1182/blood.V116.21.1904.1904
Published: 2010
Journal Articles

Arsenic Trioxide-Mediated Growth Inhibition of Myeloma Cells Is Associated with An Extrinsic Signaling Pathway Involved in Caspase 3 and Caspase 8.

Jumei Shi, MD., PhD, Yi Wu, Siqing Wang, MD, MS, Xiuqin Meng, MD., Rong Wei, MD., Xiaojing Hu, MD., PhD, Maurizio Zangari, MD, Guido J. Tricot, MD., PhD, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4899.
https://doi.org/10.1182/blood.V114.22.4899.4899
Published: 2009
Journal Articles

Adoptively Transferred Expanded Natural Killer Cells Inhibit Myeloma Tumor Growth In Vivo .

Tarun K. Garg, PhD, Susann Szmania, BS, Paul Malbrough, BS, Charles Ekworomadu, MS, Katie Stone, BS, Amberly Moreno-Bost, BS, Emily Woods, BS, Jumei Shi, MD, PhD, Shmuel Yaccoby, PhD, John D Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Dario Campana, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 953.
https://doi.org/10.1182/blood.V114.22.953.953
Published: 2009
Journal Articles

Activation and Expansion of Natural Killer (NK) Cells with Potent Cytotoxicity for Multiple Myeloma

Jumei Shi, MD, PhD, Susann Szmania, BS, Guido Tricot, MD, PhD, Tarun K. Garg, PhD, Priyangi A Malaviarachchi, BS, Amberly Moreno-Bost, BS, Katie Stone, BS, Fenghuang Zhan, MD, PhD, Dario Campana, MD, PhD, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2758.
https://doi.org/10.1182/blood.V112.11.2758.2758
Published: 2008
Journal Articles

Ex Vivo Activated Natural Killer (NK) Cells from Myeloma Patients Kill Autologous Myeloma and Killing Is Enhanced by Elotuzumab

Tarun K. Garg, PhD, Susann Szmania, BS, Jumei Shi, MD, PhD, Katie Stone, BS, Amberly Moreno-Bost, BS, Paul Malbrough, BS, Dario Campana, MD., PhD, Bart Barlogie, MD, PhD, Daniel Afar, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3666.
https://doi.org/10.1182/blood.V112.11.3666.3666
Published: 2008
Journal Articles

Recognition of Myeloma by MAGE-A3 Specific Cytotoxic T Lymphocytes Induced by Treatment with Azacitidine and MGCD0103

Amberly Moreno-Bost, BS, Susann Szmania, BS, Katie Stone, BS, Jumei Shi, MD, PhD, Tarun K. Garg, PhD, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Hugh Grant Prentice, MD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3674.
https://doi.org/10.1182/blood.V112.11.3674.3674
Published: 2008
Journal Articles

A Novel Mechanism of Action of Bortezomib: Proteasome Inhibition Down-Regulates HLA-Class I on Myeloma and Enhances NK Cell-Mediated Lysis.

Jumei Shi, MD, PhD, Guido J. Tricot, MD, PhD, Priyangi A. Malaviarachchi, Tarun K. Garg, PhD, Susann M. Szmania, Arend Mulder, PhD, John D. Shaughnessy, PhD, Bart Barlogie, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1525.
https://doi.org/10.1182/blood.V110.11.1525.1525
Published: 2007
Journal Articles

Bortezomib Down-Regulates HLA Class I and Enhances Natural Killer Cell Mediated Lysis of Myeloma.

Jumei Shi, MD, PhD, Tarun K. Garg, PhD, Rachel E. Kellum, BS, Susann M. Szmania, BS, Bart Barlogie, MD, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3498.
https://doi.org/10.1182/blood.V108.11.3498.3498
Published: 2006
Journal Articles

Stimulation with K562 Cells Transfected with 4-1BBL and IL-15 Expands and Activates Natural Killer (NK) Cells with Specific Cytotoxicity for Multiple Myeloma (MM).

Jumei Shi, MD, PhD, Guido Tricot, MD, PhD, Susann Szmania, BS, Cristyn Camet, BS, Nancy Rosen, BS, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Dario Campana, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3392.
https://doi.org/10.1182/blood.V106.11.3392.3392
Published: 2005
Journal Articles

KIR-LIGAND Mismatched Natural Killer Cells Effectively Kill Primary Myeloma and Myeloma Cell Lines.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, JuMei Shi, MD, PhD, Michele Cottler-Fox, MD, Justin W. Dyniewski, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2449.
https://doi.org/10.1182/blood.V104.11.2449.2449
Published: 2004
Journal Articles

Soluble and Membrane Bound MICA in Myeloma Do Not Adversely Effect Regulation of Natural Killer Cell Function Via NKG2D..

Jumei Shi, MD, PhD, Susann Szmania, BS, Fenghuang Zhan, PhD, John Shaughnessy, PhD, Bart Barlogie, MD, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2462.
https://doi.org/10.1182/blood.V104.11.2462.2462
Published: 2004